Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liuwei Dihuang Pills for Postmenopausal Osteoporosis Mechanism
NCT01834105Phase 2Unknown
- Sponsor
- Fujian Academy of Traditional Chinese Medicine
- Start
- Jan 2012
- Primary completion
- Dec 2014
- Modality
- Herbal formula
- Countries
- 1
01
Overview
Phase 2 trial of liu wei di huang wan in postmenopausal osteoporosis (2 arms), sponsored by Fujian Academy of Traditional Chinese Medicine. Primary endpoint: Osteoporosis treatment efficacy at 6 months. Status: unknown.
02
Drugs
liu wei di huang wan
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT01834105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01834105.